{"product_id":"vascular-dementia-isbn-9780879934255","title":"Vascular Dementia","description":"Vascular dementia (VAD) accounts for one-third of all dementias in today''s aging population, second only to Alzheimer's disease (DAT). Fortunately, current imaging techniques allow clinicians to view specific lesions in the brain, classify them by etiology and anatomical location, and assess changes using serial imaging, while at the same time correlating those changes with signs and symptoms of VAD or DAT. In 17 chapters, this book summarizes new concepts concerning the epidemiology, etiology, risk factors, neuropathology and pathogenesis of VAD and DAT, and mixtures of the two, and reviews their multiple causes, including microvascular and hemorrhagic lesions, and ischemic and inflammatory changes affecting both white and gray matter. \u003cp\u003eContributors iii\u003c\/p\u003e \u003cp\u003eForeword Honorary editor: James F. Toole, President of World Federation of Neurology iv\u003cbr\u003ePreface Editors: John S. Meyer, Gaiane M. Rauch, Helmut Lechner, Carlo Loeb, James F. Toole vi\u003c\/p\u003e \u003cp\u003eChapter 1 Epidemiology of Vascular Dementia 1\u003cbr\u003eMd. Anwarul Haque, John S. Meyer, Gaiane M. Rauch\u003c\/p\u003e \u003cp\u003eChapter 2 Cardiovascular Risk Factors Contributors to Cerebral Degenerative Changes, Cognitive Decline, and Dementia 19\u003cbr\u003eJohn S. Meyer, Gaiane M. Rauch, Ronald A. Rauch\u003c\/p\u003e \u003cp\u003eChapter 3 Risk Factors for Vascular Dementia 41\u003cbr\u003eHelmut Lechner\u003c\/p\u003e \u003cp\u003eChapter 4 Neuropathological Correlates of Vascular Dementia 59\u003cbr\u003eCarlo Loeb\u003c\/p\u003e \u003cp\u003eChapter 5 Microvascular Pathology in Vascular and Related Dementias 77\u003cbr\u003eAlberto Portera-Sanchez, Jesus Porta-Etessam\u003c\/p\u003e \u003cp\u003eChapter 6 Recent Advances in Vascular Dementia Research 101\u003cbr\u003eDavid W. Desmond\u003c\/p\u003e \u003cp\u003eChapter 7 Clinical Feautures of Patients with Vascular Dementia Versus Alzheiner’s Disease 119\u003cbr\u003eGaiane M. Rauch, john S. Meyer\u003c\/p\u003e \u003cp\u003eChapter 8 Neuropsychological Assessments for Cognitive Decline 131\u003cbr\u003eMd. Anwarul Haque, John S. Meyer, Gaiane M. Rauch\u003c\/p\u003e \u003cp\u003eChapter 9 Subcortical Arteriosclerotic Encephalopathy Binswanger Type or Chronic Microvascular Leukoencephalopathy Syndrome 155\u003cbr\u003eCarlo Loeb\u003c\/p\u003e \u003cp\u003eChapter 10 Criteria for Diagnosis of Vascular Dementia 181\u003cbr\u003eCarlo Loeb, John S. Meyer, Gaiane M. Rauch\u003c\/p\u003e \u003cp\u003eChapter 11 Classification of Subtypes of Vascular Dementia Including Subcortical Versus Cortical Dementias 203\u003cbr\u003eJohn S. Meyer, Gaiane M. Rauch\u003c\/p\u003e \u003cp\u003eChapter 12 Neuroimaging in Vascular Dementia 221\u003cbr\u003eJohn S. Meyer, Gaiane M. Rauch. Ronald A. Rauch\u003c\/p\u003e \u003cp\u003eChapter 13 Clinical Observation During Long-Term Follow-Up of Outcome in Vascular Dementia 235\u003cbr\u003eHelmut Lechner, Gotz Bertha\u003c\/p\u003e \u003cp\u003eChapter 14 Prevention and Treatment of Vascular Dementia 251\u003cbr\u003eJohn S. Meyer, Gaiane M. Rauch\u003c\/p\u003e \u003cp\u003eChapter 15 Scientific Basis for Plasmapheresis in Vascular Dementia 263\u003cbr\u003eHelmut Lechner\u003c\/p\u003e \u003cp\u003eChapter 16 Estrogen Therapy for Prevention of Dementia in Postmenopausal Women 279\u003cbr\u003eGaiane M. Rauch, John S. Meyer\u003c\/p\u003e \u003cp\u003eChapter 17 Factors Influencing Long-Term Survival Among Patients with Vascular Dementia Versus Alzheimer’s Disease 289\u003cbr\u003eJohn S. Meyer, Gaiane M. Rauch\u003c\/p\u003e \u003cp\u003eIndex 307\u003c\/p\u003e \u003cp\u003e\u003cb\u003eJohn Meyer\u003c\/b\u003e is the editor of \u003ci\u003eVascular Dementia\u003c\/i\u003e, published by Wiley.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eGaiane Rauch\u003c\/b\u003e is the editor of \u003ci\u003eVascular Dementia\u003c\/i\u003e, published by Wiley.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eHelmut Lechner\u003c\/b\u003e is the editor of \u003ci\u003eVascular Dementia\u003c\/i\u003e, published by Wiley.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCarlo Loeb\u003c\/b\u003e is the editor of \u003ci\u003eVascular Dementia\u003c\/i\u003e, published by Wiley.\u003c\/p\u003e  Vascular dementia (VAD) accounts for one-third of all dementias in today''s aging population, second only to Alzheimer's disease (DAT). Fortunately, current imaging techniques allow clinicians to view specific lesions in the brain, classify them by etiology and anatomical location, and assess changes using serial imaging, while at the same time correlating those changes with signs and symptoms of VAD or DAT. In 17 chapters, this book summarizes new concepts concerning the epidemiology, etiology, risk factors, neuropathology and pathogenesis of VAD and DAT, and mixtures of the two, and reviews their multiple causes, including microvascular and hemorrhagic lesions, and ischemic and inflammatory changes affecting both white and gray matter.  \u003cp\u003eFor the first time, the subject of reversible cognitive decline among the elderly is described, and early control of vascular risk factors are described that can improve early cognitive decline and prevent strokes and dementia.\u003c\/p\u003e \u003cp\u003eVascular dementia (VAD) accounts for one-third of all dementias in today''s aging population, second only to Alzheimer''s disease (DAT). Fortunately, current imaging techniques allow clinicians to view specific lesions in the brain, classify them by etiology and anatomical location, and assess changes using serial imaging, while at the same time correlating those changes with signs and symptoms of VAD or DAT. In 17 chapters, this book summarizes new concepts concerning the epidemiology, etiology, risk factors, neuropathology and pathogenesis of VAD and DAT, and mixtures of the two, and reviews their multiple causes, including microvascular and hemorrhagic lesions, and ischemic and inflammatory changes affecting both white and gray matter.\u003c\/p\u003e \u003cp\u003eFor the first time, the subject of reversible cognitive decline is described in detail, and early control of vascular risk factors are discussed that can improve, prevent or reverse early cognitive decline and prevent strokes and dementia. Clinical features of patients with VAD are compared to those with DAT, so that similarities and differences in the clinical course of both diseases are apparent. Simple and practical methods for assessing and quantifying cognitive and neurobehavioral deteriorations are discussed, as well as issues for prevention and therapy.\u003c\/p\u003e \u003cp\u003eNeurologists, vascular surgeons, internists, family practitioners, nurses, rehabilitationists and clinical psychologists will all find this text practical, useful and informative.\u003c\/p\u003e","brand":"Wiley-Blackwell","offers":[{"title":"Default Title","offer_id":47990447702245,"sku":"NP9780879934255","price":268.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9780879934255.jpg?v=1761787868","url":"https:\/\/k12savings.com\/products\/vascular-dementia-isbn-9780879934255","provider":"K12savings","version":"1.0","type":"link"}